Literature DB >> 31673553

Liver resection versus chemoembolization for patients with multifocal hepatocellular carcinoma.

Victor M Zaydfudim1, Reid B Adams1.   

Abstract

Entities:  

Year:  2019        PMID： 31673553      PMCID： PMC6791989          DOI： 10.21037/hbsn.2019.04.12

Source DB:  PubMed          Journal:  Hepatobiliary Surg Nutr        ISSN： 2304-3881            Impact factor:   7.293


× No keyword cloud information.
  10 in total

1.  Liver Resection and Transplantation for Patients With Hepatocellular Carcinoma Beyond Milan Criteria.

Authors:  Victor M Zaydfudim; Neeta Vachharajani; Goran B Klintmalm; William R Jarnagin; Alan W Hemming; Maria B Majella Doyle; Keith M Cavaness; William C Chapman; David M Nagorney
Journal:  Ann Surg       Date:  2016-10       Impact factor: 12.969

2.  Surgical treatment of hepatocellular carcinoma in North America: can hepatic resection still be justified?

Authors:  William C Chapman; Goran Klintmalm; Alan Hemming; Neeta Vachharajani; Maria B Majella Doyle; Ron DeMatteo; Victor Zaydfudim; Haniee Chung; Keith Cavaness; Robert Goldstein; Ivan Zendajas; Laleh G Melstrom; David Nagorney; William Jarnagin
Journal:  J Am Coll Surg       Date:  2015-01-06       Impact factor: 6.113

3.  Average treatment effect of hepatic resection versus locoregional therapies for hepatocellular carcinoma.

Authors:  A Cucchetti; V Mazzaferro; A D Pinna; C Sposito; R Golfieri; C Serra; C Spreafico; F Piscaglia; A Cappelli; M Bongini; M Cucchi; M Cescon
Journal:  Br J Surg       Date:  2017-07-26       Impact factor: 6.939

Review 4.  Molecular therapies and precision medicine for hepatocellular carcinoma.

Authors:  Josep M Llovet; Robert Montal; Daniela Sia; Richard S Finn
Journal:  Nat Rev Clin Oncol       Date:  2018-10       Impact factor: 66.675

5.  Liver Resection for Multiple Hepatocellular Carcinomas: A Japanese Nationwide Survey.

Authors:  Yasuyuki Fukami; Yuji Kaneoka; Atsuyuki Maeda; Takashi Kumada; Junko Tanaka; Tomoyuki Akita; Shoji Kubo; Namiki Izumi; Masumi Kadoya; Michiie Sakamoto; Osamu Nakashima; Yutaka Matsuyama; Takashi Kokudo; Kiyoshi Hasegawa; Tatsuya Yamashita; Kosuke Kashiwabara; Tadatoshi Takayama; Norihiro Kokudo; Masatoshi Kudo
Journal:  Ann Surg       Date:  2020-07       Impact factor: 12.969

6.  Curative salvage liver transplantation in patients with cirrhosis and hepatocellular carcinoma: An intention-to-treat analysis.

Authors:  Robbert J de Haas; Chetana Lim; Prashant Bhangui; Chady Salloum; Philippe Compagnon; Cyrille Feray; Julien Calderaro; Alain Luciani; Daniel Azoulay
Journal:  Hepatology       Date:  2017-11-15       Impact factor: 17.425

7.  Surgical resection versus transarterial chemoembolization for BCLC intermediate stage hepatocellular carcinoma: a systematic review and meta-analysis.

Authors:  Lei Liang; Hao Xing; Han Zhang; Jianhong Zhong; Chao Li; Wan Yee Lau; Mengchao Wu; Feng Shen; Tian Yang
Journal:  HPB (Oxford)       Date:  2017-11-22       Impact factor: 3.647

8.  Challenges in patient selection for liver resection or transplantation in patients with hepatocellular carcinoma beyond Milan criteria.

Authors:  Victor M Zaydfudim; William C Chapman; David M Nagorney
Journal:  Hepatobiliary Surg Nutr       Date:  2017-08       Impact factor: 7.293

9.  Salvage Versus Primary Liver Transplantation for Early Hepatocellular Carcinoma: Do Both Strategies Yield Similar Outcomes?

Authors:  Prashant Bhangui; Marc Antoine Allard; Eric Vibert; Daniel Cherqui; Gilles Pelletier; Antonio Sa Cunha; Catherine Guettier; Jean-Charles Duclos Vallee; Faouzi Saliba; Henri Bismuth; Didier Samuel; Denis Castaing; René Adam
Journal:  Ann Surg       Date:  2016-07       Impact factor: 12.969

Review 10.  Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?

Authors:  Joseph M Obeid; Paul R Kunk; Victor M Zaydfudim; Timothy N Bullock; Craig L Slingluff; Osama E Rahma
Journal:  Cancer Immunol Immunother       Date:  2017-10-20       Impact factor: 6.968
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.